As the world battled through the pandemic, VC investment in biotech & pharma thrived in 2020. The industry saw $28.5 billion invested across 1,073 deals—a 60.5% year-on-year increase—as investors recognized the importance of vaccine development. PitchBook’s latest analyst note explores how supercharged investor interest in innovative biotech startups has driven the sector beyond its early-year projections and why VC-backed biotech & pharma financings are expected to remain strong this year.
Read the full article: PitchBook Analyst Note: Biotech Went to Work as the World Stayed Home //
Source: https://pitchbook.com/news/reports/q1-2021-pitchbook-analyst-note-biotech-went-to-work-as-the-world-stayed-home